FEBRX Mutual Fund

NAV$16.73

Fund Essentials - as of Jan 31, 2026

Net Assets
$135M
Expense Ratio
0.84%
Dividend Yield (Current)
3.63%
Holdings
237
Inception Date
Mar 1, 2017
Fund Family
First Eagle Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Monthly
SEC 30-Day Yield
••••••••••

Performance

YTD+6.15%
1 Year+18.37%
3 Year+14.51%
5 Year+9.20%

Asset Allocation

Stocks: 66.27%
Bonds: 24.25%
Cash: 0.46%
Other: 9.03%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
-Philadelphia Pa 5.25 08/01/20458.89%
BATS:LNBritish American Tobacco Plc Common Stock GBP 253.22%
J36:BMJardine Matheson Holdings Ltd. Shs2.58%
BDXBecton Dickinson and Company2.11%
UL:LNUnilever PLC2.08%
Top 10 Concentration: 27.25%Report Date: Jan 31, 2026
Download all 237 holdings for FEBRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.63%
Frequency
Monthly
Latest Distribution
$0.23
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

FEBRX Mutual Fund Overview

FEBRX Mutual Fund (First Eagle Global Balanced Fund Class R6) is managed by First Eagle Investments with $134.5M in net assets. FEBRX expense ratio is 0.84%, holding 237 positions across sectors including Unknown, Financials, Other. Inception date: 2017-03-01.

FEBRX performance shows a YTD return of 6.15%. The 1-year return is 18.37% and the 5-year return is 9.20%. FEBRX dividend yield stands at 3.63%, paid monthly.

FEBRX top holdings include Philadelphia Pa 5.25 08/01/2045 (8.9%), British American Tobacco Plc Common Stock GBP 25 (3.2%), Jardine Matheson Holdings Ltd. Shs (2.6%), Becton Dickinson and Company (2.1%), Unilever PLC (2.1%). View all FEBRX holdings, sector breakdown, or dividend history.

FEBRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FEBRX alternatives are available via the screener, along with tax-loss harvesting opportunities.